Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.69 |
| ▸ | TSHR | P16473 | 1/20 | 0.69 |
| ▸ | CA1 | P00915 | 1/20 | 0.59 |
| ▸ | CA2 | P00918 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | HTT | P42858 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.46 |
| ▸ | FABP4 | P15090 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL28097128 | 0.98 | TP53 (0.67) | TP53TSHRCA1CA2L3MBTL1 | |
| SCHEMBL28102124 | 0.82 | TP53 (0.64) | TP53TSHRCA1CA2ALDH1A1 | |
| SCHEMBL4728733 | 0.81 | TP53 (0.63) | TP53TSHRL3MBTL1MEN1KMT2A | |
| SCHEMBL31024013 | 0.78 | TP53 (0.59) | TP53TSHRCA1CA2KMT2A | |
| SCHEMBL14273105 | 0.77 | CA1 (0.62) | CA1CA2L3MBTL1MEN1KMT2A | |
| SCHEMBL10801457 | 0.77 | SMN1; SMN2 (0.65) | TP53TSHRL3MBTL1MEN1KMT2A | |
| SCHEMBL288347 | 0.76 | FKBP1A (0.49) | TP53TSHRCA1CA2L3MBTL1 | |
| SCHEMBL27676576 | 0.76 | TP53 (0.63) | TP53TSHRCA1CA2L3MBTL1 | |
| SCHEMBL14216332 | 0.76 | CA1 (0.47) | TP53TSHRCA1CA2L3MBTL1 | |
| SCHEMBL1364805 | 0.75 | CA1 (1.00) | CA1CA2L3MBTL1ALDH1A1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 618 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12194448-B2 | Catalysts for the transformation of carbon dioxide and glycerol to formic acid and lactic acid and methods of making the same | THE GEORGE WASHINGTON UNIVERSITY (US) | 2025-01-14 | — | — | US | claimed |
| CN-117317221-A | High-first-efficiency high-power hard carbon negative electrode material and preparation method thereof | 安徽天宏基科技有限公司 | 2023-12-29 | — | — | CN | claimed |
| CN-116396587-A | In-situ aluminum nitride frame/polymer composite material and preparation method thereof | 海南大学 | 2023-07-07 | — | — | CN | claimed |
| CN-116355353-A | Silicon nitride whisker reinforced silicon carbide/polymer composite material and preparation method thereof | 海南大学 | 2023-06-30 | — | — | CN | claimed |
| CN-116355354-A | Silicon carbide frame/polymer composite material and preparation method thereof | 海南大学 | 2023-06-30 | — | — | CN | claimed |
| CN-115418149-A | Non-asphalt-based non-cured waterproof coating and preparation method thereof | 北京东方雨虹防水技术股份有限公司 | 2022-12-02 | — | — | CN | claimed |
| CN-111548356-B | Process for preparing tert-butyl-1, 8-dioxa-4, 11-diazaspiro [5.6] dodecane-11-carboxylic acid ester | 无锡合全药业有限公司 | 2022-05-17 | — | — | CN | claimed |
| CN-109942762-B | Preparation method of surface treating agent with flame retardant property | 上海普信高分子材料有限公司 | 2021-10-22 | — | — | CN | claimed |
| CN-112961375-A | Chitosan-based self-repairing hydrogel and preparation method thereof | 广东工业大学 | 2021-06-15 | — | — | CN | claimed |
| CN-112280272-A | High-molecular packaging material and preparation method thereof | 程朝刚 | 2021-01-29 | — | — | CN | claimed |
| WO-2002099023-A2 | ENZYMATIC SYSTEMS FOR GENERATING ACTIVE OXYGEN SPECIES FOR REACTING WITH OTHER PRECURSORS TO OBTAIN OXIDATION AND/OR BLEACHING | CALL, KRIMHILD (DE) | 2002-12-12 | — | — | WO | claimed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
| EP-0251760-B1 | Rubber composition | BRIDGESTONE CORP (JP) | 1994-01-26 | — | — | EP | claimed |
| US-5140055-A | Improved high speed grip performance | BRIDGESTONE CORPORATION (JP) | 1992-08-18 | — | — | US | claimed |
| EP-0061760-B1 | A METHOD FOR PREPARING A MONONUCLEOTIDE-3'-PHOSPHODIESTER-BASED SUBSTRATE | Baker Instruments Corporation (US) | 1988-03-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12194448-B2 | Catalysts for the transformation of carbon dioxide and glycerol to formic acid and lactic acid and methods of making the same | MLX, LDHA, CA2 | TP53 2528/4885TSHR 2120/4885CA1 13/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.